DockoMatic - Automated Peptide Analog Creation for High Throughput Virtual Screening

The purpose of this manuscript is threefold: (1) to describe an update to DockoMatic that allows the user to generate cyclic peptide analog structure files based on protein database (pdb) files, (2) to test the accuracy of the peptide analog structure generation utility, and (3) to evaluate the high throughput capacity of DockoMatic. The DockoMatic graphical user interface interfaces with the software program Treepack to create user defined peptide analogs. To validate this approach, DockoMatic produced cyclic peptide analogs were tested for three‐dimensional structure consistency and binding affinity against four experimentally determined peptide structure files available in the Research Collaboratory for Structural Bioinformatics database. The peptides used to evaluate this new functionality were alpha‐conotoxins ImI, PnIA, and their published analogs. Peptide analogs were generated by DockoMatic and tested for their ability to bind to X‐ray crystal structure models of the acetylcholine binding protein originating from Aplysia californica. The results, consisting of more than 300 simulations, demonstrate that DockoMatic predicts the binding energy of peptide structures to within 3.5 kcal mol−1, and the orientation of bound ligand compares to within 1.8 Å root mean square deviation for ligand structures as compared to experimental data. Evaluation of high throughput virtual screening capacity demonstrated that Dockomatic can collect, evaluate, and summarize the output of 10,000 AutoDock jobs in less than 2 hours of computational time, while 100,000 jobs requires approximately 15 hours and 1,000,000 jobs is estimated to take up to a week. © 2011 Wiley Periodicals, Inc. J Comput Chem, 2011

[1]  Journal of Molecular Biology , 1959, Nature.

[2]  Bonnie Berger,et al.  Fast and accurate algorithms for protein side-chain packing , 2006, JACM.

[3]  Jinbo Xu,et al.  Rapid Protein Side-Chain Packing via Tree Decomposition , 2005, RECOMB.

[4]  D. Groebe,et al.  alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. , 1995, Molecular pharmacology.

[5]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[6]  Reed B. Jacob,et al.  Dockomatic - automated ligand creation and docking , 2010, BMC Research Notes.

[7]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[8]  F. Guissard,et al.  Biochemical Pharmacology , 1960, Nature.

[9]  Sébastien Dutertre,et al.  Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors. , 2004, European journal of biochemistry.

[10]  Sébastien Dutertre,et al.  Toxin insights into nicotinic acetylcholine receptors. , 2006, Biochemical pharmacology.

[11]  David J. Craik,et al.  Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors. , 2004, European journal of biochemistry.

[12]  C. Liébecq European Journal of Biochemistry , 1967, Springer Berlin Heidelberg.

[13]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[14]  Michael J. Marks,et al.  Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors , 2004 .

[15]  Pedro Alexandrino Fernandes,et al.  Protein–ligand docking: Current status and future challenges , 2006, Proteins.

[16]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[17]  P. Sexton,et al.  Molecular Pharmacology , 1965, Nature.